{
  "meta": {
    "id": "test60",
    "title": "Mid Day Module (OBG-7) - 2025-03-09",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 32-year P3 comes to OPD with AUB. Menarche was at age 13 years, and she has had regular cycles till 1 year ago. She then began to have delayed periods every 45-60 days with heavy bleeding, clots but no cramping. She has not had her period in 4 months. She has no hot flushes, acne, or abnormal hair growth. She takes levo-thyroxine for hypothyroidism and has had a tubal ligation done. Height is 160 cm, weight is 120kg. P/S is normal. Bimanual exam is limited by body habitus. A urine pregnancy test is negative. Lab tests are as follows: TSH- 2.9, Prolactin: 16, LH: 15 What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Primary ovarian insufficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anovulation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Leiomyoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypothyroidism",
          "correct": false
        }
      ],
      "correct_answer": "B. Anovulation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This patient is having anovulatory cycles. This is because She is obese and this causes insulin resistance and hyperglycemia with decreased production of SHBG causing elevated androgen levels. This androgen gets aromatized to estrone which leads to persistent elevated estrogen levels. This results in anovulation due to the imbalance in LH and FSH (High LH: FSH ratio in PCOS which is the commonest cause of anovulatory cycles)</li><li>\u2022 This patient is having anovulatory cycles. This is because She is obese and this causes insulin resistance and hyperglycemia with decreased production of SHBG causing elevated androgen levels. This androgen gets aromatized to estrone which leads to persistent elevated estrogen levels. This results in anovulation due to the imbalance in LH and FSH (High LH: FSH ratio in PCOS which is the commonest cause of anovulatory cycles)</li><li>\u2022 She is obese and this causes insulin resistance and hyperglycemia with decreased production of SHBG causing elevated androgen levels. This androgen gets aromatized to estrone which leads to persistent elevated estrogen levels. This results in anovulation due to the imbalance in LH and FSH (High LH: FSH ratio in PCOS which is the commonest cause of anovulatory cycles)</li><li>\u2022 She is obese and this causes insulin resistance and hyperglycemia with decreased production of SHBG causing elevated androgen levels.</li><li>\u2022 This androgen gets aromatized to estrone which leads to persistent elevated estrogen levels.</li><li>\u2022 This results in anovulation due to the imbalance in LH and FSH (High LH: FSH ratio in PCOS which is the commonest cause of anovulatory cycles)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 This is not primary ovarian insufficiency as there are no hot flushes which mean estrogen levels are normal/ high Her TSH levels are normal so this is not hypothyroidism Leiomyoma presents as heavy bleeding in regular cycles.</li><li>\u2022 This is not primary ovarian insufficiency as there are no hot flushes which mean estrogen levels are normal/ high</li><li>\u2022 Her TSH levels are normal so this is not hypothyroidism</li><li>\u2022 Leiomyoma presents as heavy bleeding in regular cycles.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Anovular cycles are common in women with high BMI</li><li>\u27a4 Anovular cycles are common in women with high BMI</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7820e6a",
      "audio": ""
    },
    {
      "text": "Which of the following is a contraindication for the image given below?",
      "options": [
        {
          "label": "A",
          "text": "Adenomyosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Large submucosal fibroid",
          "correct": true
        },
        {
          "label": "C",
          "text": "Simple endometrial hyperplasia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nulliparous woman",
          "correct": false
        }
      ],
      "correct_answer": "B. Large submucosal fibroid",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/10/untitled-696.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 This is an image of an intra-uterine device Contra-indications to Intrauterine Devices include Pregnancy Puerperal Sepsis Septic Abortion Unexplained vaginal bleeding Gestational trophoblastic disease Cervical cancer Endometrial cancer Distorted uterine cavity (Pre-existing uterine fibroids that distort the uterine cavity may be incompatible with insertion and proper placement of the IUD) PID</li><li>\u2022 This is an image of an intra-uterine device</li><li>\u2022 Contra-indications to Intrauterine Devices include</li><li>\u2022 Pregnancy</li><li>\u2022 Puerperal Sepsis</li><li>\u2022 Septic Abortion</li><li>\u2022 Unexplained vaginal bleeding</li><li>\u2022 Gestational trophoblastic disease</li><li>\u2022 Cervical cancer</li><li>\u2022 Endometrial cancer</li><li>\u2022 Distorted uterine cavity (Pre-existing uterine fibroids that distort the uterine cavity may be incompatible with insertion and proper placement of the IUD)</li><li>\u2022 PID</li><li>\u2022 Let us look at each option :</li><li>\u2022 Option A. Adenomyosis : Adenomyosis, a condition where the inner lining of the uterus (endometrium) breaks through the muscle wall of the uterus, is not a contraindication for IUD use, it  helps in reducing the heavy menstrual bleeding associated with adenomyosis.</li><li>\u2022 Option A.</li><li>\u2022 Adenomyosis</li><li>\u2022 Option B . Large Submucosal Fibroid (Correct Answer): A large submucosal fibroid, which protrudes into the uterine cavity, can distort the uterine cavity and interfere with the proper placement and function of an IUD. This can increase the risk of expulsion, malposition, or even perforation, making it a contraindication for IUD use.</li><li>\u2022 Option B</li><li>\u2022 Large Submucosal Fibroid</li><li>\u2022 Option C . Simple Endometrial Hyperplasia : Simple endometrial hyperplasia without atypia is generally not a contraindication for IUD use. In fact, hormonal IUDs that release progestin can be part of the treatment plan for endometrial hyperplasia.</li><li>\u2022 Option C</li><li>\u2022 Simple Endometrial Hyperplasia</li><li>\u2022 Option D . Nulliparous Woman : While historically there was hesitation in using IUDs in nulliparous women, current evidence supports the safety and efficacy of IUDs in this population.</li><li>\u2022 Option D</li><li>\u2022 Nulliparous Woman</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Large submucosal fibroids that distort the uterine cavity are a contraindication for IUD use due to the potential for complications such as expulsion or perforation. Other conditions like adenomyosis, simple endometrial hyperplasia without atypia, or being a nulliparous woman are not contraindications for IUD use.</li><li>\u27a4 Ref: Williams Textbook of Gynecology 3 rd edition page 109</li><li>\u27a4 Ref: Williams Textbook of Gynecology 3 rd edition page 109</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b93cf9cf",
      "audio": ""
    },
    {
      "text": "The Anti-progesterone compound RU-486 is effective for inducing abortion if the duration of pregnancy is?",
      "options": [
        {
          "label": "A",
          "text": "63 days",
          "correct": true
        },
        {
          "label": "B",
          "text": "72 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "84 days",
          "correct": false
        },
        {
          "label": "D",
          "text": "90 days",
          "correct": false
        }
      ],
      "correct_answer": "A. 63 days",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 63 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 RU-486 is Mifepristone and along with Misoprostol, it is used for medical methods of abortion.</li><li>\u2022 RU-486 is Mifepristone and along with Misoprostol, it is used for medical methods of abortion.</li><li>\u2022 A combi pack of mifepristone and misoprostol (one tablet of mifepristone 200mg and four tablets of misoprostol 200mcg each) has been approved by the Central Drugs Standard Control Organization, Directorate General of Health Services, for the medical termination of pregnancy up to n ee9ks (63 days) LMP in December 2008 However; CAC Training & Service Delivery Guidelines, 2016 by MoHFW, GoI recommends its use up to 49 days (7 weeks) in public sector sites, in line with the MTP Rules 2003. A proposed amendment to the MTP Act, 1971, to increase the gestation limit for MMA to 9 weeks in public sector sites is under process. Till the proposal is approved , MMA in public health facility would be allowed only up to 7 weeks. So if the question asks approved for use in public health facility, the answer will be 49 days, but it can be given till 9 weeks of pregnancy</li><li>\u2022 A combi pack of mifepristone and misoprostol (one tablet of mifepristone 200mg and four tablets of misoprostol 200mcg each) has been approved by the Central Drugs Standard Control Organization, Directorate General of Health Services, for the medical termination of pregnancy up to n ee9ks (63 days) LMP in December 2008</li><li>\u2022 However; CAC Training & Service Delivery Guidelines, 2016 by MoHFW, GoI recommends its use up to 49 days (7 weeks) in public sector sites, in line with the MTP Rules 2003.</li><li>\u2022 A proposed amendment to the MTP Act, 1971, to increase the gestation limit for MMA to 9 weeks in public sector sites is under process. Till the proposal is approved , MMA in public health facility would be allowed only up to 7 weeks.</li><li>\u2022 , MMA in public health facility would be allowed only up to 7 weeks.</li><li>\u2022 So if the question asks approved for use in public health facility, the answer will be 49 days, but it can be given till 9 weeks of pregnancy</li><li>\u2022 So if the question asks approved for use in public health facility, the answer will be 49 days, but it can be given till 9 weeks of pregnancy</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B, C and D all have duration > 63 days. Betwen 9 - 12 weeks, suction evacuation is preferred. After 12 weeks, a medical abortion is again preferred (i.e. different regimes of mifepristone f/b misoprostol have been described).</li><li>\u2022 Option B, C and D all have duration > 63 days. Betwen 9 - 12 weeks, suction evacuation is preferred. After 12 weeks, a medical abortion is again preferred (i.e. different regimes of mifepristone f/b misoprostol have been described).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A combi pack of mifepristone and misoprostol (one tablet of mifepristone 200mg and four tablets of misoprostol 200mcg each) has been approved by the Central Drugs Standard Control Organization, Directorate General of Health Services, for the medical termination of pregnancy up to n ee9ks (63 days) LMP in December 2008 However; CAC Training & Service Delivery Guidelines, 2016 by MoHFW, GoI recommends its use up to 49 days (7 weeks) in public sector sites, in line with the MTP Rules 2003.</li><li>\u27a4 A combi pack of mifepristone and misoprostol (one tablet of mifepristone 200mg and four tablets of misoprostol 200mcg each) has been approved by the Central Drugs Standard Control Organization, Directorate General of Health Services, for the medical termination of pregnancy up to n ee9ks (63 days) LMP in December 2008</li><li>\u27a4 However; CAC Training & Service Delivery Guidelines, 2016 by MoHFW, GoI recommends its use up to 49 days (7 weeks) in public sector sites, in line with the MTP Rules 2003.</li><li>\u27a4 Ref: https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/MMA_Handbook.pdf</li><li>\u27a4 Ref: https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/MMA_Handbook.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47cf4095",
      "audio": ""
    },
    {
      "text": "As per the 2021 amendment of the MTP act, the upper limit of gestational age for terminating a fetus with substantial anomalies is:",
      "options": [
        {
          "label": "A",
          "text": "20 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "24 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "28 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "No upper limit",
          "correct": true
        }
      ],
      "correct_answer": "D. No upper limit",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Very Important</li><li>\u2022 Very Important</li><li>\u2022 As per the 2021 MTP amendment: act, a few important changes which you have to know are that the upper limit of gestational age has been increased  as per the following:</li><li>\u2022 Till 20 weeks for original indications (maternal indication, fetal indication, failure of contraception and rape); opinion of 1 RMP required Till 24 weeks for select indications like fetal maformation, rape, humanitarian grounds and maternal diability; opinion of 2 RMPS required After 24 weeks: Only for substantial fetal malformations (No upper limit but this has to be allowed by a medical board)</li><li>\u2022 Till 20 weeks for original indications (maternal indication, fetal indication, failure of contraception and rape); opinion of 1 RMP required</li><li>\u2022 Till 24 weeks for select indications like fetal maformation, rape, humanitarian grounds and maternal diability; opinion of 2 RMPS required</li><li>\u2022 After 24 weeks: Only for substantial fetal malformations (No upper limit but this has to be allowed by a medical board)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 As per the 2021 MTP amendment: act, a few important changes which you have to know are that the upper limit of gestational age has been increased  as per the following:</li><li>\u27a4 Till 20 weeks for original indications (maternal indication, fetal indication, failure of contraception and rape); opinion of 1 RMP required Till 24 weeks for select indications like fetal maformation, rape, humanitarian grounds and maternal diability; opinion of 2 RMPS required After 24 weeks: Only for substantial fetal malformations (No upper limit but this has to be allowed by a medical board)</li><li>\u27a4 Till 20 weeks for original indications (maternal indication, fetal indication, failure of contraception and rape); opinion of 1 RMP required</li><li>\u27a4 Till 24 weeks for select indications like fetal maformation, rape, humanitarian grounds and maternal diability; opinion of 2 RMPS required</li><li>\u27a4 After 24 weeks: Only for substantial fetal malformations (No upper limit but this has to be allowed by a medical board)</li><li>\u27a4 Ref: http://164.100.47.4/BillsTexts/LSBillTexts/Asintroduced/55_2020_LS_Eng.pdf</li><li>\u27a4 Ref:</li><li>\u27a4 http://164.100.47.4/BillsTexts/LSBillTexts/Asintroduced/55_2020_LS_Eng.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd0e0f48",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman underwent hysterectomy with bilateral salpingooophorectomy with pelvic and para-aortic lymphadenectomy for endometrial cancer. Histopathology confirms lymph node involvement. Which of the following statements is correct:",
      "options": [
        {
          "label": "A",
          "text": "The patient has stage IIIb disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "No further treatment required as lymphadenectomy already done",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lymphadenectomy in endometrial cancer helps in staging and guiding further management",
          "correct": true
        },
        {
          "label": "D",
          "text": "The patient will require adjuvant vaginal brachytherappy",
          "correct": false
        }
      ],
      "correct_answer": "C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management",
      "question_images": [],
      "explanation_images": [
        "https://pbs.twimg.com/media/FzFlF3IWAAUU5Rn?format=jpg&name=900x900"
      ],
      "explanation": "<p><strong>Ans. C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Figo cancer report 2021</li><li>\u27a4 Ref: Figo cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d22d3d7a",
      "audio": ""
    },
    {
      "text": "Which of the following arrows depicts where the uterosacral ligament is ligated during a type II radical hysterectomy?",
      "options": [
        {
          "label": "A",
          "text": "A",
          "correct": false
        },
        {
          "label": "B",
          "text": "B",
          "correct": true
        },
        {
          "label": "C",
          "text": "C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anywhere",
          "correct": false
        }
      ],
      "correct_answer": "B. B",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/whatsapp-image-2023-12-18-at-174605.jpeg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/screenshot-2023-12-18-180615.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Types of Hysterectomy</li><li>\u2022 Types of Hysterectomy</li><li>\u2022 In this image, they have shown the utero-sacral ligaments and have asked about a type 2 hysterectomy; hence midway is the best answer</li><li>\u2022 In this image, they have shown the utero-sacral ligaments and have asked about a type 2 hysterectomy; hence midway is the best answer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a type 2 radical hysterectomy, the uterine vessels are ligated at the level of the ureter and the uterosacral ligaments are divided midway between the uterus and the sacrum In a type 3 hysterectomy, the uterine vessels are ligated at the origin of the internal iliac vessels and the uterosacral ligaments are ligated near the sacrum</li><li>\u27a4 In a type 2 radical hysterectomy, the uterine vessels are ligated at the level of the ureter and the uterosacral ligaments are divided midway between the uterus and the sacrum</li><li>\u27a4 In a type 3 hysterectomy, the uterine vessels are ligated at the origin of the internal iliac vessels and the uterosacral ligaments are ligated near the sacrum</li><li>\u27a4 Ref: Page 171, Williams Gynecology, 3 rd edition</li><li>\u27a4 Ref: Page 171, Williams Gynecology, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cf56df7d",
      "audio": ""
    },
    {
      "text": "Persistence of endometriosis is directly dependent on which of the following hormones?",
      "options": [
        {
          "label": "A",
          "text": "Estrogen",
          "correct": true
        },
        {
          "label": "B",
          "text": "Testosterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Progesterone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Androstenedione",
          "correct": false
        }
      ],
      "correct_answer": "A. Estrogen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Estrogen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Endometriosis is a hyperestrogenic state</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Endometriosis is a Hyperestrogenic state. Estrogen facilitates the growth of the ectopic endometrial glands. Endometriosis is an estrogen-dependent, chronic inflammatory disease with aberrant growth of ectopic endometrial tissue. The disturbed molecular mechanisms in this disease are yet to be completely defined. However, suspected underpinnings include an environment estrogen dominance, estrogen dependence, and progesterone resistance within implants; inflammation; escape from immune clearance; local invasion and neurovascular development; and genetic predisposition.</li><li>\u27a4 Endometriosis is a Hyperestrogenic state.</li><li>\u27a4 Estrogen facilitates the growth of the ectopic endometrial glands.</li><li>\u27a4 Endometriosis is an estrogen-dependent, chronic inflammatory disease with aberrant growth of ectopic endometrial tissue.</li><li>\u27a4 The disturbed molecular mechanisms in this disease are yet to be completely defined. However, suspected underpinnings include an environment estrogen dominance, estrogen dependence, and progesterone resistance within implants; inflammation; escape from immune clearance; local invasion and neurovascular development; and genetic predisposition.</li><li>\u27a4 Ref: Page no 233, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 233, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1747917c",
      "audio": ""
    },
    {
      "text": "In the pelvic inlet, which is the shortest anteroposterior diameter?",
      "options": [
        {
          "label": "A",
          "text": "True conjugate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Obstetric conjugate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Anatomical conjugate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bispinous diameter",
          "correct": false
        }
      ],
      "correct_answer": "B. Obstetric conjugate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Obstetric conjugate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Diameters of the Pelvic Inlet</li><li>\u27a4 Diameters of the Pelvic Inlet</li><li>\u27a4 Anteroposterior (AP) Diameter</li><li>\u27a4 Anteroposterior (AP) Diameter</li><li>\u27a4 True (anatomical) conjugate (11 cm): Extends from uppermost margin of symphysis pubis to the sacral promontory. Obstetric conjugate (10 cm): It is the shortest AP diameter of the pelvic inlet and hence obstetrically most important. It is measured from the middle of sacral promontory to symphysis pubis. It cannot be measured directly on clinical examination. It is calculated by subtracting 1.5 cm from diagonal conjugate. Diagonal conjugate (12.5 cm): It is measured from tip of sacral promontory to the lower margin of pubic symphysis. It is the only diameter that can be assessed clinically.</li><li>\u27a4 True (anatomical) conjugate (11 cm): Extends from uppermost margin of symphysis pubis to the sacral promontory.</li><li>\u27a4 True (anatomical) conjugate (11 cm):</li><li>\u27a4 Obstetric conjugate (10 cm): It is the shortest AP diameter of the pelvic inlet and hence obstetrically most important. It is measured from the middle of sacral promontory to symphysis pubis. It cannot be measured directly on clinical examination. It is calculated by subtracting 1.5 cm from diagonal conjugate.</li><li>\u27a4 Obstetric conjugate (10 cm):</li><li>\u27a4 Diagonal conjugate (12.5 cm): It is measured from tip of sacral promontory to the lower margin of pubic symphysis. It is the only diameter that can be assessed clinically.</li><li>\u27a4 Diagonal conjugate (12.5 cm):</li><li>\u27a4 Transverse Diameter (13 cm)</li><li>\u27a4 Transverse Diameter (13 cm)</li><li>\u27a4 Distance between the farthest two points on the iliopectineal line. It is the largest diameter of pelvic inlet</li><li>\u27a4 Distance between the farthest two points on the iliopectineal line.</li><li>\u27a4 It is the largest diameter of pelvic inlet</li><li>\u27a4 Oblique Diameters (12 cm)</li><li>\u27a4 Oblique Diameters (12 cm)</li><li>\u27a4 Right oblique diameter: Passes from right sacroiliac joint to left ilio-pubiceminence Left oblique diameter: Passes from left sacroiliac joint to right ilio-pubic eminence</li><li>\u27a4 Right oblique diameter: Passes from right sacroiliac joint to left ilio-pubiceminence</li><li>\u27a4 Left oblique diameter: Passes from left sacroiliac joint to right ilio-pubic eminence</li><li>\u27a4 Ref: Page no 92 Textbook of obstetrics by JB Sharma</li><li>\u27a4 Ref: Page no 92 Textbook of obstetrics by JB Sharma</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd1ca0d4",
      "audio": ""
    },
    {
      "text": "A 32-year G2 presents to the antenatal OPD. Her period of gestation is 40 weeks. She is planned for induction of labor. On a vaginal exam, the cervix is 2 cm dilated, 1 cm long, soft inconsistency and mid-position. The station of the fetal head is at -1. She asks if induction of labor will be successful? What will you tell her?",
      "options": [
        {
          "label": "A",
          "text": "She will not respond favorably to induction of labor and will require pre-induction cervical ripening",
          "correct": false
        },
        {
          "label": "B",
          "text": "She will not respond favorably to induction and LSCS should be done",
          "correct": false
        },
        {
          "label": "C",
          "text": "She will respond favorably to induction of labor",
          "correct": true
        },
        {
          "label": "D",
          "text": "The given information is insufficient to make a conclusion",
          "correct": false
        }
      ],
      "correct_answer": "C. She will respond favorably to induction of labor",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-162846.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-162931.jpg"
      ],
      "explanation": "<p><strong>Ans. C. She will respond favorably to induction of labor</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Bishop score is as shown in the table. Each component is scored from 0 to 3 The highest score is 13 and the lowest is 0 A favourable score is > 6. This means the patient will respond favorably to methods of induction of labor.</li><li>\u27a4 The Bishop score is as shown in the table.</li><li>\u27a4 Each component is scored from 0 to 3</li><li>\u27a4 The highest score is 13 and the lowest is 0</li><li>\u27a4 A favourable score is > 6. This means the patient will respond favorably to methods of induction of labor.</li><li>\u27a4 Ref: Page no 247, Textbook of Obstetrics by JB Sharma, 3 rd edition</li><li>\u27a4 Ref: Page no 247, Textbook of Obstetrics by JB Sharma, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4fa8dbca",
      "audio": ""
    },
    {
      "text": "Mrs. Shiny, a G2P1L1 presented to the hospital in labor pains. On examination she had 3 uterine contractions of 20 seconds in 10 minutes, Cervical dilation was 6 cm and HR 145 bpm. What is the stage of labor?",
      "options": [
        {
          "label": "A",
          "text": "Stage I",
          "correct": true
        },
        {
          "label": "B",
          "text": "Stage II",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stage III",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stage IV",
          "correct": false
        }
      ],
      "correct_answer": "A. Stage I",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Stage I</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal Labor</li><li>\u27a4 Normal Labor</li><li>\u27a4 Uterine contractions which bring about cervical effacement and dilatation.</li><li>\u27a4 Stage 1:</li><li>\u27a4 Stage 1:</li><li>\u27a4 From 0 cm to 10 cm dilatation Divided into latent phase and active phase. Latent phase: The point at which mother perceives regular contractions. Active phase: Cervical dilatation of 4cm (as per the WHO modified partograph) 5 cm (As per the new WHO labor care guide) 6 cm (As per ACOG).</li><li>\u27a4 From 0 cm to 10 cm dilatation</li><li>\u27a4 Divided into latent phase and active phase.</li><li>\u27a4 Latent phase: The point at which mother perceives regular contractions.</li><li>\u27a4 Active phase: Cervical dilatation of 4cm (as per the WHO modified partograph) 5 cm (As per the new WHO labor care guide) 6 cm (As per ACOG).</li><li>\u27a4 4cm (as per the WHO modified partograph) 5 cm (As per the new WHO labor care guide) 6 cm (As per ACOG).</li><li>\u27a4 4cm (as per the WHO modified partograph)</li><li>\u27a4 5 cm (As per the new WHO labor care guide)</li><li>\u27a4 6 cm (As per ACOG).</li><li>\u27a4 Stage 2:</li><li>\u27a4 Stage 2:</li><li>\u27a4 Complete cervical dilatation with active expulsive efforts by the mother</li><li>\u27a4 Complete cervical dilatation with active expulsive efforts by the mother</li><li>\u27a4 Stage 3:</li><li>\u27a4 Stage 3:</li><li>\u27a4 Delivery of placenta and membranes</li><li>\u27a4 Delivery of placenta and membranes</li><li>\u27a4 Stage 4:</li><li>\u27a4 Stage 4:</li><li>\u27a4 \u201cThe Golden hour\u201d One hour after delivery of baby. The mother should be monitored for signs of post-partum hemorrhage.</li><li>\u27a4 \u201cThe Golden hour\u201d</li><li>\u27a4 One hour after delivery of baby. The mother should be monitored for signs of post-partum hemorrhage.</li><li>\u27a4 Ref: Page no 227, Textbook of Obstetrics by JB Sharma, 3 rd edition</li><li>\u27a4 Ref: Page no 227, Textbook of Obstetrics by JB Sharma, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73cb102e",
      "audio": ""
    },
    {
      "text": "A 32yr G2P1 is referred at her 36 weeks from the primary health center with prolonged labor. On examination, the patient is dehydrated. Abdominal examination reveals a 32 weeks uterus which is tonically contracted. The presentation is unclear. Fetal heart rate is absent. On local examination, the hand is seen outside the introitus. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Cesarean section",
          "correct": true
        },
        {
          "label": "B",
          "text": "Decapitation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reposit the hand back and external version",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reposit the hand back and internal version",
          "correct": false
        }
      ],
      "correct_answer": "A. Cesarean section",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Cesarean section</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "08d7a813",
      "audio": ""
    },
    {
      "text": "All are risk factors for shoulder dystocia except?",
      "options": [
        {
          "label": "A",
          "text": "Previous shoulder dystocia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Macrosomia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primigravida",
          "correct": true
        },
        {
          "label": "D",
          "text": "Vacuum delivery",
          "correct": false
        }
      ],
      "correct_answer": "C. Primigravida",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk factors for shoulder dystocia include</li><li>\u27a4 Previous shoulder dystocia Macrosomia Diabetes Obesity Induced labor Prolonged labor Vacuum and forceps (more common with vacuum) Anencephaly Multiparity Post maturity</li><li>\u27a4 Previous shoulder dystocia</li><li>\u27a4 Macrosomia</li><li>\u27a4 Diabetes</li><li>\u27a4 Obesity</li><li>\u27a4 Induced labor</li><li>\u27a4 Prolonged labor</li><li>\u27a4 Vacuum and forceps (more common with vacuum)</li><li>\u27a4 Anencephaly</li><li>\u27a4 Multiparity</li><li>\u27a4 Post maturity</li><li>\u27a4 ReF: Page no 469, DC Duttas textbook of Obstetrics 8 th edition</li><li>\u27a4 ReF: Page no 469, DC Duttas textbook of Obstetrics 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e126fcc",
      "audio": ""
    },
    {
      "text": "A 22-year-old woman who is otherwise healthy, has an uneventful vaginal delivery of a full-term infant. One day postpartum, she complains of visual changes and a severe headache. Two hours after this, she is found unresponsive and profoundly hypotensive. She is intubated and put on mechanical ventilation. Her BP is 68/28 mmHg. Heart rate is 140 bp. O2 saturation is 95% on FiO2 of 0.40. Physical exam is unremarkable. Lab tests are notable for glucose of 48 mg/ dl with a normal hematocrit and TLC. Which of the following will reverse her hypotension?",
      "options": [
        {
          "label": "A",
          "text": "Activated drotrecogin alfa.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hydrocortisone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thyroxine (T4)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Transfusion of packed red blood cells",
          "correct": false
        }
      ],
      "correct_answer": "B. Hydrocortisone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Hydrocortisone</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2de44103",
      "audio": ""
    },
    {
      "text": "External rotation occurs after the head is born. The head moves by 45\u02daand this occurs because?",
      "options": [
        {
          "label": "A",
          "text": "Rotation of the neck",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rotation of the shoulders",
          "correct": true
        },
        {
          "label": "C",
          "text": "Untwisting of the neck",
          "correct": false
        },
        {
          "label": "D",
          "text": "Untwisting of the shoulders",
          "correct": false
        }
      ],
      "correct_answer": "B. Rotation of the shoulders",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Rotation of the shoulders</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The cardinal movement of external rotation is actually internal rotation of the shoulders</li><li>\u27a4 The cardinal movement of external rotation is actually internal rotation of the shoulders</li><li>\u27a4 Ref: Page no 224, JB Sharma\u2019s Textbook of Obstetrics 3 rd edition</li><li>\u27a4 Ref: Page no 224, JB Sharma\u2019s Textbook of Obstetrics 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "787ea7f7",
      "audio": ""
    },
    {
      "text": "A 23y woman has a suction evacuation for molar pregnancy. The HPE is reported as a partial mole. You counsel her that her risk of progression to gestational trophoblastic neoplasia is?",
      "options": [
        {
          "label": "A",
          "text": "1-5%",
          "correct": true
        },
        {
          "label": "B",
          "text": "5-10%",
          "correct": false
        },
        {
          "label": "C",
          "text": "10-15%",
          "correct": false
        },
        {
          "label": "D",
          "text": "15-20%",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-5%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 1-5%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk of progress of complete mole to GTN: 15-20 % Risk of progress of partial mole to GTN: 1-5%</li><li>\u27a4 Risk of progress of complete mole to GTN: 15-20 %</li><li>\u27a4 Risk of progress of partial mole to GTN: 1-5%</li><li>\u27a4 Ref: Page 393, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 393, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d452f62f",
      "audio": ""
    },
    {
      "text": "Match the following correctly:",
      "options": [
        {
          "label": "A",
          "text": "1b 2d 3c 4a",
          "correct": false
        },
        {
          "label": "B",
          "text": "1a 2d 3c 4b",
          "correct": true
        },
        {
          "label": "C",
          "text": "1a 2c 3d 4b",
          "correct": false
        },
        {
          "label": "D",
          "text": "1b 2c 3d 4a",
          "correct": false
        }
      ],
      "correct_answer": "B. 1a 2d 3c 4b",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113312.JPG"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640.JPG",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113640_kvczIXj.JPG"
      ],
      "explanation": "<p><strong>Ans. B. 1a 2d 3c 4b</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Remember this very important table</li><li>\u2022 Remember this very important table</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Remember this very important table</li><li>\u27a4 Remember this very important table</li><li>\u27a4 Ref: DC Dutta\u2019s Textbook of Contraception</li><li>\u27a4 Ref: DC Dutta\u2019s Textbook of Contraception</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0155094",
      "audio": ""
    },
    {
      "text": "What is the preferred schedule of immunization in pregnancy regarding tetanus as per the ministry of health and family welfare?",
      "options": [
        {
          "label": "A",
          "text": "Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inj TT 1 st dose early in pregnancy, 2 nd dose after 4 weeks and booster if received 2 TT doses in a pregnancy within the last 3 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inj Tdap 1 st dose in the 2 nd trimester and 2 nd dose in the 3 rd trimester",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inj TT or Td 1 st dose in early pregnancy and 2 nd dose after 4 weeks.",
          "correct": false
        }
      ],
      "correct_answer": "A. Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inj Td: 1stdose: early in pregnancy, 2nddose: After 4 weeks; booster:\u00a0 if received 2 Td doses in a pregnancy within the last 3 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap</li><li>\u2022 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 Td has replaced TT (as per MOHFW)</li><li>\u2022 1 st dose: early in pregnancy</li><li>\u2022 2 nd dose: After 4 weeks</li><li>\u2022 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap</li><li>\u27a4 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 Td has replaced TT (as per MOHFW)</li><li>\u27a4 1 st dose: early in pregnancy</li><li>\u27a4 2 nd dose: After 4 weeks</li><li>\u27a4 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 Ref : https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li><li>\u27a4 Ref :</li><li>\u27a4 https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f02d6de6",
      "audio": ""
    },
    {
      "text": "A raised uterine pulsatility index at 11-14 weeks on uterine artery doppler is a predictor for?",
      "options": [
        {
          "label": "A",
          "text": "Down Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gestational Diabetes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placenta previa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Preeclampsia",
          "correct": true
        }
      ],
      "correct_answer": "D. Preeclampsia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Preeclampsia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow. Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term</li><li>\u2022 Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow.</li><li>\u2022 Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia</li><li>\u2022 Gestational HTN</li><li>\u2022 Fetal growth restriction</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Gestational HTN</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c13aa563",
      "audio": ""
    },
    {
      "text": "Lithium in pregnancy is associated with an increased incidence of?",
      "options": [
        {
          "label": "A",
          "text": "Orofacial clefting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ebstein anomaly",
          "correct": true
        },
        {
          "label": "C",
          "text": "Neurobehavioral abnormalities",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cardiovascular anomalies",
          "correct": false
        }
      ],
      "correct_answer": "B. Ebstein anomaly",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Ebstein anomaly</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u2022 Fetal ECHO is indicated in women on Lithium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u27a4 Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb4fac9b",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman presents to the OPD with complaints of 3 months pregnancy with vaginal bleeding. On examination, the uterus is palpable. An ultrasound shows the following picture. What is the best management option?",
      "options": [
        {
          "label": "A",
          "text": "Mifepristone + Misoprostol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Conservative management",
          "correct": false
        },
        {
          "label": "C",
          "text": "Suction & Evacuation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hysterotomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Suction & Evacuation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/4.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Treatment of a molar pregnancy is suction and evacuation followed by beta hCG surveilance</li><li>\u27a4 Ref: Page no. 391, 392 William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no. 391, 392 William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fad818eb",
      "audio": ""
    },
    {
      "text": "Double Decidual Sac sign is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Early intra-uterine pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intra-uterine pseudo gestational sac",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tubal ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Molar pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "A. Early intra-uterine pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-329.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Early Intra \u2013 uterine pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Double decidual sac sign is seen in an intra-uterine pregnancy.</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus</li><li>\u2022 Option B:</li><li>\u2022 intra-uterine pseudo sac</li><li>\u2022 Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign</li><li>\u2022 Option C:</li><li>\u2022 Tubal ectopic pregnancy:</li><li>\u2022 Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option D:</li><li>\u2022 Molar pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP) Especially useful when the yolk sac or embryo is still not visualized. It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac) It is seen as two concentric rings surrounding an anechoic gestational sac. Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP)</li><li>\u27a4 Especially useful when the yolk sac or embryo is still not visualized.</li><li>\u27a4 It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac)</li><li>\u27a4 It is seen as two concentric rings surrounding an anechoic gestational sac.</li><li>\u27a4 Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Another sign of an intra-uterine pregnancy is the intra-decidual sign.</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e5c5027",
      "audio": ""
    },
    {
      "text": "A 16-year-old girl presents to OPD and the below examination finding is seen. Which of the following is least likely?",
      "options": [
        {
          "label": "A",
          "text": "Associated with hematometra and hamatocolpos",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cyclic pelvic pain is experienced",
          "correct": false
        },
        {
          "label": "C",
          "text": "Breast development is absent/ delayed",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cruciate incision will relieve symptoms",
          "correct": false
        }
      ],
      "correct_answer": "C. Breast development is absent/ delayed",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/whatsapp-image-2023-04-29-at-154259.jpeg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Breast development is absent/ delayed</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f76ffa0",
      "audio": ""
    },
    {
      "text": "A 14-year-old girl presents to OPD with primary amenorrhea. Her height is 135 cm. She has a webbed neck and increased carrying angle. Breast development is tanner 1 with widely spaced nipple, external genitalia are infantile. The Karyotype is most likely to reveal:",
      "options": [
        {
          "label": "A",
          "text": "46 XX",
          "correct": false
        },
        {
          "label": "B",
          "text": "46XY",
          "correct": false
        },
        {
          "label": "C",
          "text": "45 X0",
          "correct": true
        },
        {
          "label": "D",
          "text": "47 XXY",
          "correct": false
        }
      ],
      "correct_answer": "C. 45 X0",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 45 X0</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "887e2a6c",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to OPD with complaint of secondary amenorrhea. On examination, there is galactorrhoea, and her prolactin levels are high. Urine pregnancy test is negative. Which of the following is treatment of choice for her:",
      "options": [
        {
          "label": "A",
          "text": "OCP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cabergoline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dexamethasone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxytocin",
          "correct": false
        }
      ],
      "correct_answer": "B. Cabergoline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cabergoline</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref:</li><li>\u27a4 Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d6242d6",
      "audio": ""
    },
    {
      "text": "A curious pregnant patient visits the antenatal OPD. She has missed her period by 4 days and her pregnancy test is positive. This is her 1 st pregnancy and although, sex detection is banned in India, she is very curious about how the baby forms and asks if it is possible to know the sex of the baby now. You tell her that the gonads are undifferentiated at present. The gonads are bipotent till?",
      "options": [
        {
          "label": "A",
          "text": "5 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "6 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "7 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "8 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 5 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/screenshot-2024-04-24-113705.JPG"
      ],
      "explanation": "<p><strong>Ans. A. 5 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li><li>\u2022 The gonads are BIPOTENT (Undifferentiated) till 5 weeks, they then differentiate into testes or ovaries based on whether the karyotype is 46XX or 46XY</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "606eb05c",
      "audio": ""
    },
    {
      "text": "You are assisting the surgeon in an abdominal myomectomy. The surgeon applies this instrument. Where would this be applied?",
      "options": [
        {
          "label": "A",
          "text": "At the infundibulopelvic ligaments",
          "correct": false
        },
        {
          "label": "B",
          "text": "At the level of round ligaments",
          "correct": false
        },
        {
          "label": "C",
          "text": "At the level of the internal os",
          "correct": true
        },
        {
          "label": "D",
          "text": "At the level of the fibroid",
          "correct": false
        }
      ],
      "correct_answer": "C. At the level of the internal os",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/1.jpg"
      ],
      "explanation": "<p><strong>Ans. C. At the level of the internal os</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This is a Bonney\u2019s myomectomy clamp It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u2022 This is a Bonney\u2019s myomectomy clamp</li><li>\u2022 It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is a Bonney\u2019s myomectomy clamp It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u27a4 This is a Bonney\u2019s myomectomy clamp</li><li>\u27a4 It is applied at the level of the uterine arteries  (level of internal os) during abdominal myomectomy to reduce the intra-operative blood loss by occluding the uterine arteries temporarily</li><li>\u27a4 Ref: Page no 527, DC Dutta\u2019s Textbook of Gynecology 7 th edition</li><li>\u27a4 Ref: Page no 527, DC Dutta\u2019s Textbook of Gynecology 7 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3e88c8e",
      "audio": ""
    },
    {
      "text": "A 30 y comes to OPD for evaluation of absent periods. The patient had a vaginal delivery 8 months ago and she\u2019s not had her period since delivery. Her postpartum course was complicated by secondary PPH requiring blood transfusion and a D & E for retained products. At a visit, 2 months ago, the patient was started on combined OCPs, and she has not had vaginal bleeding. Prior to this pregnancy she had regular monthly cycles. She also has increased fatigue. She is not lactating and is bottle feeding her baby. There is no headache, galactorrhoea, or hot flushes. BMI is 31, vitals are normal. Pelvic examination shows clear vaginal discharge and well rugate vagina. The uterus is small and anteverted. UPT is negative. FSH and TSH are normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asherman syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sheehan syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "PCOS",
          "correct": false
        },
        {
          "label": "D",
          "text": "Primary ovarian insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Asherman syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Asherman syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Asherman syndrome is intra uterine adhesions, they arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Asherman syndrome is intra uterine adhesions, they arise due to: Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium Uterine artery embolization Endometrial ablative procedures Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Surgical trauma to the uterus which may be seen following Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp. sharp curettage) Cesarean section Myomectomy where the endometrial cavity is involved Metroplasty Trans-cervical resection of the endometrium</li><li>\u27a4 Dilatation and curettage (esp. sharp curettage)</li><li>\u27a4 Cesarean section</li><li>\u27a4 Myomectomy where the endometrial cavity is involved</li><li>\u27a4 Metroplasty</li><li>\u27a4 Trans-cervical resection of the endometrium</li><li>\u27a4 Uterine artery embolization</li><li>\u27a4 Endometrial ablative procedures</li><li>\u27a4 Intra-uterine infections like tuberculosis and schistosomiasis</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility Diagnosis On ultrasound</li><li>\u27a4 Symptoms: Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea Secondary amenorrhoea Secondary infertility</li><li>\u27a4 Hypomenorrhea</li><li>\u27a4 Secondary amenorrhoea</li><li>\u27a4 Secondary infertility</li><li>\u27a4 Diagnosis On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 On ultrasound</li><li>\u27a4 Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 Uterine cavity appears irregular/ i nterrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 On HSG Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Intra-uterine filling defects are seen giving a moth-eaten appearance</li><li>\u27a4 Hysteroscopy Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Gold standard for diagnosis</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Treatment: Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Hysteroscopic adhesiolysis Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Hysteroscopic adhesiolysis</li><li>\u27a4 Post procedure: To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</li><li>\u27a4 Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. Top of Form</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d7c2a04",
      "audio": ""
    },
    {
      "text": "Preeti, a 20-year-old girl presents with a history of rapidly developing hirsutism, severe acne and amenorrhea. Her BMI is 19. To establish the diagnosis, which would be the most appropriate blood test?",
      "options": [
        {
          "label": "A",
          "text": "17-OH progesterone",
          "correct": false
        },
        {
          "label": "B",
          "text": "DHEA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Testosterone",
          "correct": true
        },
        {
          "label": "D",
          "text": "LH: FSH ratio",
          "correct": false
        }
      ],
      "correct_answer": "C. Testosterone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Testosterone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page 449, Speroff\u2019s clinical gynecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be02a63f",
      "audio": ""
    },
    {
      "text": "The most common degeneration seen in uterine fibroids is",
      "options": [
        {
          "label": "A",
          "text": "Calcific degeneration",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fatty degeneration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyaline degeneration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Red degeneration",
          "correct": false
        }
      ],
      "correct_answer": "C. Hyaline degeneration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hyaline degeneration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u2022 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u2022 Red degeneration, calcific degeneration and fatty degeneration are other kinds of degeneration in fibroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u27a4 The most common type of degeneration in fibroids is hyaline degeneration</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li><li>\u27a4 Ref: Page no 227, DC Dutta\u2019s Textbook of gynecology</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "649ff5aa",
      "audio": ""
    },
    {
      "text": "A 34-year nulliparous woman presents to the OPD. She complains of pelvic heaviness. She also mentions that her periods have been increasingly heavy in amount and she has to take a pain killer on the 1 st 2 days of her period due to excessive pain. The periods are otherwise regular. On examination, there is an irregular mass palpated abdominally which is about the size of an 18 weeks gravid uterus. On bimanual exam, the same irregular mass is felt and there is transmitted mobility. What is the possible diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Adenomyosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fibroid polyp",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leiomyoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ovarian mass",
          "correct": false
        }
      ],
      "correct_answer": "C. Leiomyoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Leiomyoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This patient has symptoms of heavy menstrual bleed and dysmenorrhea which are seen in adenomyosis, fibroids (leiomyoma) and polyp. On examination, this is  a fibroid (probably multiple fibroids) The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 This patient has symptoms of heavy menstrual bleed and dysmenorrhea which are seen in adenomyosis, fibroids (leiomyoma) and polyp.</li><li>\u2022 On examination, this is  a fibroid (probably multiple fibroids) The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 The uterus is significantly enlarged and irregular There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses) The woman is nulliparous</li><li>\u2022 The uterus is significantly enlarged and irregular</li><li>\u2022 There is transmitted mobility i.e. the mass is arising from the uterus (transmitted mobility is absent in ovarian masses)</li><li>\u2022 The woman is nulliparous</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 In adenomyosis, the uterus is regularly enlarged (max size of 12-14 weeks size) In fibroid polyp, the uterus will be normal or slightly enlarged in size and on speculum exam, a polyp may be seen extruding from the os. Fibroid polyps usually present with inter menstrual bleeding or irregular bleeding In ovarian mass, there usually won't be any menstrual symptoms, also transmitted mobility will be absent (i.e. on moving the mass, the cervix will not be felt to move)</li><li>\u2022 In adenomyosis, the uterus is regularly enlarged (max size of 12-14 weeks size)</li><li>\u2022 In fibroid polyp, the uterus will be normal or slightly enlarged in size and on speculum exam, a polyp may be seen extruding from the os. Fibroid polyps usually present with inter menstrual bleeding or irregular bleeding</li><li>\u2022 In ovarian mass, there usually won't be any menstrual symptoms, also transmitted mobility will be absent (i.e. on moving the mass, the cervix will not be felt to move)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 C/f of fibroid uterus</li><li>\u27a4 C/f of fibroid uterus</li><li>\u27a4 Symptoms</li><li>\u27a4 Symptoms</li><li>\u27a4 Menorrhagia Dysmenorrhoea Infertility Abdominal mass and pressure symptoms</li><li>\u27a4 Menorrhagia</li><li>\u27a4 Dysmenorrhoea</li><li>\u27a4 Infertility</li><li>\u27a4 Abdominal mass and pressure symptoms</li><li>\u27a4 Signs:</li><li>\u27a4 Signs:</li><li>\u27a4 Uterus regularly enlarged (single fibroid) or irregularly enlarged (multiple fibroids) Transmitted mobility is felt in a fibroid</li><li>\u27a4 Uterus regularly enlarged (single fibroid) or irregularly enlarged (multiple fibroids)</li><li>\u27a4 Transmitted mobility is felt in a fibroid</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li><li>\u27a4 Ref: Page 376, DC Duttas\u2019s Textbook of Gynecology 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9728220d",
      "audio": ""
    },
    {
      "text": "A 17-year-old woman presents to OPD with painful menstruation. On examination, normal secondary sexual characters are present. The vagina is patent but shows a bulge on the right side near the cervix. On per rectal examination, there is a bulge felt about 4 cm from anal verge and is more towards left side. On Ultrasound, there is hematocolpos and the left side kidney is absent. Diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "OHVIRA syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "MRKH syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "ACUM",
          "correct": false
        },
        {
          "label": "D",
          "text": "Robert\u2019s uterus",
          "correct": false
        }
      ],
      "correct_answer": "A. OHVIRA syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747_O1cNPjD.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-110058.jpg"
      ],
      "explanation": "<p><strong>Ans. A. OHVIRA syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li><li>\u27a4 Ref: Speroff\u2019s 9 th edition chapter 10, amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "54b07c05",
      "audio": ""
    },
    {
      "text": "Which of the following is not a part of HELLP syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Hemolysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated liver enzymes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thrombocytopenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Retroplacental hemorrhage",
          "correct": true
        }
      ],
      "correct_answer": "D. Retroplacental hemorrhage",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Retroplacental hemorrhage</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 HELLP Syndrome</li><li>\u27a4 HELLP Syndrome</li><li>\u27a4 It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3 It is a rare complication of pregnancy induced hypertension. It may be associated even with mild hypertension and proteinuria</li><li>\u27a4 It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3</li><li>\u27a4 It is a rare complication of pregnancy induced hypertension.</li><li>\u27a4 It may be associated even with mild hypertension and proteinuria</li><li>\u27a4 Ref: Page no 1849, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1849, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6962b606",
      "audio": ""
    },
    {
      "text": "Identify the maternal condition that can lead to the findings in the baby as shown below",
      "options": [
        {
          "label": "A",
          "text": "Pre-gestational diabetes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gestational diabetes mellitus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Effect of valproate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertensive on ACE inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "A. Pre-gestational diabetes",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture14_kY8nI7M.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Pre-gestational diabetes</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus. The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</li><li>\u27a4 Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus.</li><li>\u27a4 The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</li><li>\u27a4 Ref: Page 1110, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 1110, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d8386d9",
      "audio": ""
    },
    {
      "text": "A 30y primigravida presents in labor at 38 weeks. The resident notes that she is HBsAg positive. Which of the following statements regarding immunization of a newborn born to a HBsAg positive mother is true?",
      "options": [
        {
          "label": "A",
          "text": "Hep-B Vaccine should be administered within 24 hours of birth",
          "correct": false
        },
        {
          "label": "B",
          "text": "HBIG should be administered within 12 hours of birth.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hep-B Vaccine and HBIG should be administered within 12 hours of birth",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hep-B Vaccine and HBIG should be administered within 24 hours of birth",
          "correct": false
        }
      ],
      "correct_answer": "C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth)</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Williams Obstetrics 25 th edition Page 1065</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "55d21930",
      "audio": ""
    },
    {
      "text": "A 37-year lady with chronic hypertension visits the gynecologist for pre-conceptional counselling. She is currently taking Telmisartan for her hypertension. Which is the correct statement?",
      "options": [
        {
          "label": "A",
          "text": "Stop Telmisartan 3 months prior to conception and re-start it at the 3 rd month of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stop Telmisartan 3 months pre-conceptionally and start Labetalol",
          "correct": true
        },
        {
          "label": "C",
          "text": "Continue Telmisartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy.</li><li>\u27a4 ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy.</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82b2881a",
      "audio": ""
    },
    {
      "text": "All of the following indicate superimposed pre-eclampsia in a pregnant female of chronic hypertension except:",
      "options": [
        {
          "label": "A",
          "text": "New onset proteinuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet count < 75,000",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fresh retinal hypertensive changes",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-192932.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-193029.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 1780, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1780, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e63fdf76",
      "audio": ""
    },
    {
      "text": "A 24-year G2P1L1 teacher presents at 22 weeks with fever and rash since 2 days. She gives history of contact with a child in her class who had chicken pox 10 days earlier. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Consider termination of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral Acyclovir, antipyretics, and hydration",
          "correct": true
        },
        {
          "label": "C",
          "text": "IV Acyclovir",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella Zoster Immunoglobulin (VZIG)",
          "correct": false
        }
      ],
      "correct_answer": "B. Oral Acyclovir, antipyretics, and hydration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Oral Acyclovir, antipyretics, and hydration</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bff2a912",
      "audio": ""
    },
    {
      "text": "A 25-year-old P2L2 had just delivered following induction for severe preeclampsia. Her BP on the 2 nd postnatal day is 160/100mmHg. Which anti-hypertensive should be avoided in a breastfeeding mother?",
      "options": [
        {
          "label": "A",
          "text": "Amlodipine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Labetalol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Captopril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nifedipine",
          "correct": false
        }
      ],
      "correct_answer": "A. Amlodipine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Amlodipine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Antihypertensive agents with no known adverse effects on infants receiving breast milk: Mnemonic: ECLAM-N Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Antihypertensive agents with no known adverse effects on infants receiving breast milk: Mnemonic: ECLAM-N Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Mnemonic: ECLAM-N</li><li>\u27a4 Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Enalapril</li><li>\u27a4 Captopril</li><li>\u27a4 Labetalol</li><li>\u27a4 Atenolol</li><li>\u27a4 Metoprolol</li><li>\u27a4 Nifedipine</li><li>\u27a4 Ref: Smith, M , Waugh, J, Nelson\u2010Piercy, C Management of postpartum hypertension The Obstetrician & Gynecologist 2013; 15: 45\u2013 50</li><li>\u27a4 Ref: Smith, M , Waugh, J, Nelson\u2010Piercy, C Management of postpartum hypertension The Obstetrician & Gynecologist 2013; 15: 45\u2013 50</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "13bd07c8",
      "audio": ""
    },
    {
      "text": "A 28 y G2P1 presents to the OPD with a missed period and history of mild spotting PV. A urine pregnancy test done at home shows 2 lines. All are possible diagnosis except?",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": true
        },
        {
          "label": "B",
          "text": "Implantation bleed",
          "correct": false
        },
        {
          "label": "C",
          "text": "Missed abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Threatened abortion",
          "correct": false
        }
      ],
      "correct_answer": "A. Complete abortion",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/18/screenshot-2024-01-18-102826.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Complete Abortion</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Types of Spontaneous Abortion</li><li>\u27a4 Types of Spontaneous Abortion</li><li>\u27a4 Ref: Page No: 159 DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page No: 159 DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1fa10e56",
      "audio": ""
    },
    {
      "text": "A 34-year primigravida presents at 34 weeks with mild spotting. She is not in labor and the ultrasound shows the placenta in the upper segment. On evaluation, her blood group is B -negative and her husband is Rh positive. What is true regarding Anti \u2013 D prophylaxis?",
      "options": [
        {
          "label": "A",
          "text": "Anti \u2013 D prophylaxis should be given following delivery.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti -D prophylaxis should be given as soon as possible only if she has not received Anti-D prophylaxis at 28 weeks.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-D prophylaxis should be given as soon as possible even if she has received Anti-D prophylaxis at 28 weeks.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-D prophylaxis is not required.",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-D prophylaxis should be given as soon as possible even if she has received Anti-D prophylaxis at 28 weeks.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-183301.JPG"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 305, Williams Obstetrics 25 th edition)</li><li>\u27a4 Ref: Page no 305, Williams Obstetrics 25 th edition)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "62e96902",
      "audio": ""
    },
    {
      "text": "A 20-year-old girl presents to the OPD with excess facial hair for 6 months and delayed menstrual cycles. On evaluation, levels of free testosterone are increased. An ultrasound reveals normal uterus and normal ovaries on USG. The most likely diagnosis is?",
      "options": [
        {
          "label": "A",
          "text": "Adrenal hyperplasiaI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Idiopathic hirsutism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Polycystic Ovarian Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Testosterone secreting tumor",
          "correct": false
        }
      ],
      "correct_answer": "C. Polycystic Ovarian Syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture9_0mgVKz8.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Polycystic Ovarian Syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism. Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD: As per this criterion, at least 2 of 3 should be present :</li><li>\u2022 Polycystic ovarian syndrome/ disease (PCOS/PCOD) is a disorder of chronically abnormal ovarian function (oligo/anovulation) and hyperandrogenism frequently associated with hyperinsulinemia and insulin resistance, resulting in menstrual irregularity, infertility, and hirsutism.</li><li>\u2022 Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD: As per this criterion, at least 2 of 3 should be present :</li><li>\u2022 Rotterdam 2003 criteria is used to diagnose  PCOS/PCOD:</li><li>\u2022 Oligo/anovulation (causes oligomenorrhea, 2 0 amenorrhea, and infertility) Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism) 12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume > 10 mL (pearl necklace pattern).</li><li>\u2022 Oligo/anovulation (causes oligomenorrhea, 2 0 amenorrhea, and infertility)</li><li>\u2022 Hyperandrogenism: Biochemical or clinical (increased serum androgens or acne, hirsutism)</li><li>\u2022 12 or more than 12 follicle 2-9 mm in size present within 1 or both ovaries on USG and/or ovarian volume > 10 mL (pearl necklace pattern).</li><li>\u2022 USG appearance of polycystic ovaries</li><li>\u2022 As the patient in the question satisfies first 2 criteria, she is a case of PCOS</li><li>\u2022 As the patient in the question satisfies first 2 criteria, she is a case of PCOS</li><li>\u2022 let's consider the other options:</li><li>\u2022 let's consider the other options:</li><li>\u2022 Option. A. Adrenal Hyperplasia : Adrenal hyperplasia, particularly congenital adrenal hyperplasia (CAH), can cause symptoms similar to PCOS, including hirsutism and menstrual irregularities, due to elevated androgens. However, it is usually diagnosed earlier in life and often has other associated adrenal hormone abnormalities.</li><li>\u2022 Option. A.</li><li>\u2022 Adrenal Hyperplasia</li><li>\u2022 Option. B. Idiopathic Hirsutism : Idiopathic hirsutism refers to hirsutism (excess hair growth) in the absence of any identifiable hormonal imbalance or ovarian/adrenal gland disorder. Given the increased free testosterone levels in this patient, idiopathic hirsutism is less likely.</li><li>\u2022 Option. B.</li><li>\u2022 Idiopathic Hirsutism</li><li>\u2022 Option. D. Testosterone Secreting Tumor : While a testosterone-secreting tumor can cause increased androgen levels and symptoms like hirsutism, these tumors are rare. The more common presentation of such tumors would include rapid onset of symptoms and markedly elevated testosterone levels.</li><li>\u2022 Option. D.</li><li>\u2022 Testosterone Secreting Tumor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 401, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li><li>\u27a4 Ref: Page no 401, Speroff\u2019s Clinical Gynaecological endocrinology and infertility 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8d4d503",
      "audio": ""
    },
    {
      "text": "A 26y old gives a history of two 1 st trimester abortions following delivery of a preterm baby at 30 weeks due to severe preeclampsia. She is anxious and wants to be evaluated preconceptionally. Which of the following investigation will you advise?",
      "options": [
        {
          "label": "A",
          "text": "Lupus anticoagulant",
          "correct": true
        },
        {
          "label": "B",
          "text": "HBA1C",
          "correct": false
        },
        {
          "label": "C",
          "text": "TSH",
          "correct": false
        },
        {
          "label": "D",
          "text": "TORCH",
          "correct": false
        }
      ],
      "correct_answer": "A. Lupus anticoagulant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Lupus anticoagulant</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Antiphospholipid Antibody Syndrome</li><li>\u27a4 Antiphospholipid Antibody Syndrome</li><li>\u27a4 Commonly presents as RPL Diagnosed based on Sapporo\u2019s Criteria which has Lab and Clinical criteria -At least one clinical and 1 lab criteria must be present for diagnosis.</li><li>\u27a4 Commonly presents as RPL</li><li>\u27a4 Diagnosed based on Sapporo\u2019s Criteria which has Lab and Clinical criteria -At least one clinical and 1 lab criteria must be present for diagnosis.</li><li>\u27a4 Sapporo\u2019s Criteria</li><li>\u27a4 Clinical Criteria</li><li>\u27a4 Clinical Criteria</li><li>\u27a4 Obstetric</li><li>\u27a4 One or more unexplained death of a morphologically normal fetus > 10 weeks</li><li>\u27a4 One or more unexplained death of a morphologically normal fetus > 10 weeks</li><li>\u27a4 OR</li><li>\u27a4 Severe preeclampsia or placental insufficiency necessitating delivery before 34 weeks</li><li>\u27a4 Severe preeclampsia or placental insufficiency necessitating delivery before 34 weeks</li><li>\u27a4 OR</li><li>\u27a4 3 or more consecutive spontaneous abortions before 10 weeks</li><li>\u27a4 3 or more consecutive spontaneous abortions before 10 weeks</li><li>\u27a4 Vascular</li><li>\u27a4 1 or more episode of arterial/venous or small vessel thrombosis in any tissue or organ</li><li>\u27a4 1 or more episode of arterial/venous or small vessel thrombosis in any tissue or organ</li><li>\u27a4 Lab Criteria (Present on 2 or more occasions at least 12 weeks apart)</li><li>\u27a4 Lab Criteria (Present on 2 or more occasions at least 12 weeks apart)</li><li>\u27a4 Presence of lupus anticoagulant</li><li>\u27a4 Presence of lupus anticoagulant</li><li>\u27a4 OR</li><li>\u27a4 Medium to high titers of IgG or IgM anticardiolipin Antibodies</li><li>\u27a4 Medium to high titers of IgG or IgM anticardiolipin Antibodies</li><li>\u27a4 OR</li><li>\u27a4 Anti \u03b22 glycoprotein \u2013 IgG or IgM Antibody</li><li>\u27a4 Anti \u03b22 glycoprotein \u2013 IgG or IgM Antibody</li><li>\u27a4 Ref: Page no 353, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 353, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a899304d",
      "audio": ""
    },
    {
      "text": "Which is incorrect regarding the pathophysiology of placenta accrete syndromes?",
      "options": [
        {
          "label": "A",
          "text": "The abnormal adherence is due to partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Microscopically, the placental villi are found attached to smooth muscle fibers",
          "correct": false
        },
        {
          "label": "C",
          "text": "There is a close relationship between cesarean scar pregnancy (CSP) and later development of Placenta accrete syndromes in the same pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "About 15% of all accrete syndromes are placenta percreta",
          "correct": true
        }
      ],
      "correct_answer": "D. About 15% of all accrete syndromes are placenta percreta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The ratio of occurrence of placenta accreta: increta: percreta is 80:15:5; i.e. 5% of all adherent placentas are placenta percreta and hence this statement is incorrect The term placenta accreta spectrum (PAS) describes aberrant placentation characterized by abnormally implanted, invasive, or adhered placenta. It is also referred to as morbidly adherent placenta, The major problem if placenta accreta syndrome occurs is failure of placenta tto separate normally from the myometrium after fetal delivery. Attempts to seperate an adherent placenta can lead to torrential hemorrhage This abnormal adherence stems in part from partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer If the decidual spongy layer is lacking either partially or totally, the physiological line of cleavage is absent, and some or all cotyledons are densely anchored. Microscopically, placental villi attach to smooth muscle fibers rather than to decidual cells. Factors implicated in the pathogenesis An antecedent \u201cconstitutional endometrial defect\u201d in most cases is found like a history of a previous cesarean section Some tissue specimens show immunologically mediated \u201chyperinvasiveness\u201d Some genes that code for remodeling and for adherence may be highly expressed There is a close relationship between cesarean scar pregnancy (CSP) and later development of PAS in the same pregnancy.</li><li>\u2022 The ratio of occurrence of placenta accreta: increta: percreta is 80:15:5; i.e. 5% of all adherent placentas are placenta percreta and hence this statement is incorrect</li><li>\u2022 The term placenta accreta spectrum (PAS) describes aberrant placentation characterized by abnormally implanted, invasive, or adhered placenta.</li><li>\u2022 It is also referred to as morbidly adherent placenta,</li><li>\u2022 The major problem if placenta accreta syndrome occurs is failure of placenta tto separate normally from the myometrium after fetal delivery. Attempts to seperate an adherent placenta can lead to torrential hemorrhage</li><li>\u2022 This abnormal adherence stems in part from partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer</li><li>\u2022 If the decidual spongy layer is lacking either partially or totally, the physiological line of cleavage is absent, and some or all cotyledons are densely anchored.</li><li>\u2022 Microscopically, placental villi attach to smooth muscle fibers rather than to decidual cells.</li><li>\u2022 Factors implicated in the pathogenesis An antecedent \u201cconstitutional endometrial defect\u201d in most cases is found like a history of a previous cesarean section Some tissue specimens show immunologically mediated \u201chyperinvasiveness\u201d Some genes that code for remodeling and for adherence may be highly expressed There is a close relationship between cesarean scar pregnancy (CSP) and later development of PAS in the same pregnancy.</li><li>\u2022 An antecedent \u201cconstitutional endometrial defect\u201d in most cases is found like a history of a previous cesarean section Some tissue specimens show immunologically mediated \u201chyperinvasiveness\u201d Some genes that code for remodeling and for adherence may be highly expressed There is a close relationship between cesarean scar pregnancy (CSP) and later development of PAS in the same pregnancy.</li><li>\u2022 An antecedent \u201cconstitutional endometrial defect\u201d in most cases is found like a history of a previous cesarean section</li><li>\u2022 like a history of a previous cesarean section</li><li>\u2022 Some tissue specimens show immunologically mediated \u201chyperinvasiveness\u201d</li><li>\u2022 Some genes that code for remodeling and for adherence may be highly expressed</li><li>\u2022 There is a close relationship between cesarean scar pregnancy (CSP) and later development of PAS in the same pregnancy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Placenta Accrete Syndromes, the abnormal adherence stems in part from partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer</li><li>\u27a4 Ref: Page no 1974, Williams Obstetric 26 th edition</li><li>\u27a4 Ref: Page no 1974, Williams Obstetric 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c615c84",
      "audio": ""
    },
    {
      "text": "All the following have been implicated in spontaneous abortion except?",
      "options": [
        {
          "label": "A",
          "text": "Uncontrolled Diabetes mellitus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Subclinical hyperthyroidism",
          "correct": true
        },
        {
          "label": "C",
          "text": "Luteal phase defect",
          "correct": false
        },
        {
          "label": "D",
          "text": "Polycystic ovarian syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Subclinical hyperthyroidism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Subclinical hyperthyroidism</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The endocrine disorders implicated in causing spontaneous abortion are:</li><li>\u27a4 Uncontrolled diabetes mellitus Overt hypothyroidism or hyperthyroidism Subclinical hypothyroidism with antithyroid antibodies Luteal phase defect PCOS</li><li>\u27a4 Uncontrolled diabetes mellitus</li><li>\u27a4 Overt hypothyroidism or hyperthyroidism</li><li>\u27a4 Subclinical hypothyroidism with antithyroid antibodies</li><li>\u27a4 Luteal phase defect</li><li>\u27a4 PCOS</li><li>\u27a4 Ref: Page no. 347, William\u2019s 25 th edition</li><li>\u27a4 Ref: Page no. 347, William\u2019s 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ca43f802",
      "audio": ""
    },
    {
      "text": "A 36-year lady was diagnosed to have monoamniotic monochorionic twins. She is now 33 weeks. What should be the plan of management?",
      "options": [
        {
          "label": "A",
          "text": "Elective LSCS at 34 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "Elective LSCS at 37 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Induction of labor at 37 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wait for spontaneous onset of labor",
          "correct": false
        }
      ],
      "correct_answer": "A. Elective LSCS at 34 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Elective LSCS at 34 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: page no 873, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 873, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "614d0eb7",
      "audio": ""
    },
    {
      "text": "A 25-year G3P2 presented to the Antenatal clinic at 28 weeks. Her blood group is B neg and her partners blood group is B +. Indirect Coombs test revealed high titers and an MCA revealed an increased diastolic flow > 1.5 MoM with a normal peak systolic velocity. Which of the following is correct?",
      "options": [
        {
          "label": "A",
          "text": "Arrange for cordocentesis and consider Intra uterine transfusion if PCV < 30%",
          "correct": false
        },
        {
          "label": "B",
          "text": "Give Betamethasone for fetal lung maturity and deliver.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amniocentesis for amniotic fluid spectrophotometry",
          "correct": false
        },
        {
          "label": "D",
          "text": "Repeat a PSV of the MCA after 2 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. Repeat a PSV of the MCA after 2 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 303, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 303, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3ecc9c0",
      "audio": ""
    },
    {
      "text": "All are ultrasound signs of an unruptured ectopic pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Bagel sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blob sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lemon sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tubal ring",
          "correct": false
        }
      ],
      "correct_answer": "C. Lemon sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c196b0e",
      "audio": ""
    },
    {
      "text": "A 35y asthmatic was induced for FGR at 37 weeks. She is now in the 3 rd stage of labor having delivered a 2 kg female baby. Following delivery of the placenta, she starts bleeding profusely. The uterus is atonic. Which uterotone will NOT be given?",
      "options": [
        {
          "label": "A",
          "text": "Misoprostol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carboprost",
          "correct": true
        },
        {
          "label": "C",
          "text": "Syntometrine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methylergometrine",
          "correct": false
        }
      ],
      "correct_answer": "B. Carboprost",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Carboprost.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90216546",
      "audio": ""
    },
    {
      "text": "The highest risk of developing congenital varicella syndrome is?",
      "options": [
        {
          "label": "A",
          "text": "6-10 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "12-20 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "24-28 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "36 \u2013 40 weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. 12-20 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 12-20 weeks</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64f0c76a",
      "audio": ""
    },
    {
      "text": "A 24-year primigravida is diagnosed to have a twin pregnancy on her first trimester ultrasound. The following image is seen on ultrasound. What is chorionicity?",
      "options": [
        {
          "label": "A",
          "text": "Monochorionic diamniotic",
          "correct": false
        },
        {
          "label": "B",
          "text": "Monochorionic monoamniotic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dichorionic diamniotic",
          "correct": true
        },
        {
          "label": "D",
          "text": "Conjoined twins",
          "correct": false
        }
      ],
      "correct_answer": "C. Dichorionic diamniotic",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture3.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/screenshot-2024-01-06-121203.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Dichorionic diamniotic</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: page no 868-869, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 868-869, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "440aec40",
      "audio": ""
    }
  ]
}